230
Participants
Start Date
September 30, 2024
Primary Completion Date
December 5, 2024
Study Completion Date
June 13, 2025
Immuncell-LC
Activated T lymphocyte
No Interventions
Patients who were in non-treatment group in phase 3 clinical trial IIC-I01(NCT00699816).
Seoul National University Hospital, Seoul
Lead Sponsor
GC Cell Corporation
INDUSTRY